156 related articles for article (PubMed ID: 36843500)
1. Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews G; Valerio H; Dore GJ
J Viral Hepat; 2023 Jun; 30(6):520-529. PubMed ID: 36843500
[TBL] [Abstract][Full Text] [Related]
2. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
[TBL] [Abstract][Full Text] [Related]
3. Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study.
Alavi M; Law MG; Grebely J; Amin J; Hajarizadeh B; George J; Dore GJ
J Hepatol; 2016 Nov; 65(5):879-887. PubMed ID: 27401548
[TBL] [Abstract][Full Text] [Related]
4. Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection.
Jiang JJ; Shiels MS; O'Brien TR
J Viral Hepat; 2021 Jun; 28(6):934-941. PubMed ID: 33720473
[TBL] [Abstract][Full Text] [Related]
5. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.
Mocroft A; Geressu A; Beguelin C; Llibre JM; Lazarus JV; Tomazic J; Smidt J; Parczewski M; Brännström J; Sedlacek D; Degen O; van der Valk M; Paduta D; Flamholc L; Schmid P; Orkin C; Nielsen LN; Hoffmann C; Beniowski M; Oprea C; Begovac J; Peters L
AIDS; 2023 Jan; 37(1):91-103. PubMed ID: 36476454
[TBL] [Abstract][Full Text] [Related]
6. Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
Ireland G; Simmons R; Hickman M; Harris R; Ramsay M; Sabin C; Mandal S
J Viral Hepat; 2020 Jan; 27(1):20-27. PubMed ID: 31505083
[TBL] [Abstract][Full Text] [Related]
7. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
[TBL] [Abstract][Full Text] [Related]
8. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
Duffell E; Cortez-Pinto H; Simonova M; Dalgard O; Dahl EH; de Martel C; Mozalevskis A; Buti M; Pavlova S; Hadzhilova T; Simões C; Katzarov K; Mardh O
J Viral Hepat; 2021 Aug; 28(8):1177-1189. PubMed ID: 34003542
[TBL] [Abstract][Full Text] [Related]
9. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
10. Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study.
Gidding HF; Dore GJ; Amin J; Law MG
BMC Public Health; 2011 Jan; 11():52. PubMed ID: 21261993
[TBL] [Abstract][Full Text] [Related]
11. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
[TBL] [Abstract][Full Text] [Related]
12. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
13. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
[TBL] [Abstract][Full Text] [Related]
14. Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.
Samji H; Yu A; Kuo M; Alavi M; Woods R; Alvarez M; Dore GJ; Tyndall M; Krajden M; Janjua NZ;
J Hepatol; 2017 Nov; 67(5):909-917. PubMed ID: 28684103
[TBL] [Abstract][Full Text] [Related]
15. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
16. Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.
Alavi M; Grebely J; Hajarizadeh B; Amin J; Larney S; Law MG; George J; Degenhardt L; Dore GJ
BMC Infect Dis; 2018 May; 18(1):215. PubMed ID: 29743015
[TBL] [Abstract][Full Text] [Related]
17. Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan.
Chiang CJ; Jhuang JR; Yang YW; Zhuang BZ; You SL; Lee WC; Chen CJ
JAMA Netw Open; 2022 Jul; 5(7):e2222367. PubMed ID: 35849394
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]